HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

NCT/Study#

NCT02679144 /

BCC014

NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

DISEASE GROUP:
Pediatric Oncology
current phase:
Phase II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information: